Fludarabine phosphate and Compazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fludarabine phosphate (fludarabine phosphate) and Compazine (prochlorperazine maleate). Common drug interactions include neutrophil count decreased among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Fludarabine phosphate and Compazine. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Fludarabine phosphate?

Fludarabine phosphate has active ingredients of fludarabine phosphate. eHealthMe is studying from 12,840 Fludarabine phosphate users. Check the latest studies of Fludarabine phosphate.

What is Compazine?

Compazine has active ingredients of prochlorperazine maleate. It is often used in indigestion. eHealthMe is studying from 13,646 Compazine users. Check the latest studies of Compazine.

On Jul, 26, 2026

18 people who take Fludarabine phosphate and Compazine together, and have interactions are studied.

Fludarabine phosphate and Compazine drug interactions.

What are the common drug interactions of Fludarabine Phosphate and Compazine, by gender? *:

female:

Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Platelet count decreased
White blood cell count decreased
Cystitis (inflammation of the wall of the bladder)
Dysuria (painful or difficult urination)
Fatigue (feeling of tiredness)
Haematuria (presence of blood in urine)
Haemorrhage urinary tract (bleeding from uterine)
Influenza
Micturition urgency (urgency to pass the urine)

male:

Febrile neutropenia (fever with reduced white blood cells)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Aphasia (damage to the parts of the brain that control language)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Arthropathy
Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)
Back pain
Bone disorder
Bone loss

What are the common drug interactions of Fludarabine Phosphate and Compazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal pain
Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
Bacterial infection
Blood creatinine increased
Candida endophthalmitis (fungal infection of eye)
Chills (felling of cold)
Drug ineffective
Dysphagia (a condition in which swallowing is difficult or painful)
Enterococcal infection
Fatigue (feeling of tiredness)

30-39:

Neoplasm progression (growth of tumour)

40-49:

n/a

50-59:

Neuropathy peripheral (surface nerve damage)
Nocturia (the need to get up in the night to urinate)
Oropharyngeal pain
Pneumonia
Polyomavirus test positive
Respiratory failure (inadequate gas exchange by the respiratory system)
Rhinorrhoea (watery mucus discharge from the nose)
Sinus congestion (blockage of sinus)
Sinus headache (headache caused by sinus infections)
Skin hyperpigmentation (disorders affect the colour of your skin)

60+:

Febrile neutropenia (fever with reduced white blood cells)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Arthropathy
Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)
Back pain
Bone disorder
Bone loss
Bone marrow oedema (inflammation that causes much than the needed fluid in a bone)
Bone pain
Cardiomyopathy (weakening of the heart muscle)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 6 people, 33.33%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 27.78%
Diarrhea: 3 people, 16.67%
Stress And Anxiety: 3 people, 16.67%
Bone Marrow Conditioning Regimen: 3 people, 16.67%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 11.11%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 11.11%
Pain: 2 people, 11.11%
Joint Pain: 2 people, 11.11%
Hypokalemia (low potassium): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Fludarabine phosphate and Compazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously